Related Experiment Videos
Does economics matter when treating advanced non-small cell lung cancer?
Scott D Ramsey1, Larry G Kessler
1Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA. sramsey@fhcrc.org
The Oncologist
|June 18, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The vanguard study: Assessing feasibility of conducting randomized trials of novel multi-cancer detection tests.
Contemporary clinical trials·2026
Clinical harm from failure to deploy personalized medicine for patients with metastatic non-small cell lung cancer.
Journal of managed care & specialty pharmacy·2026
Immediate Release of Radiology Results in Cancer Care: Insights From a National Study of Oncology Patients.
Journal of the American College of Radiology : JACR·2026
Measuring the validity of survey questions on breast, cervical, colorectal, and lung cancer screening.
American journal of epidemiology·2026
Low agreement among the equations in healthy children and young adults.
Journal of nephrology·2026
Association between psychological wellbeing and the COVID-19-related outcomes in Europeans aged ≥ 50 years old: The SHARE study.
Human vaccines & immunotherapeutics·2026
Exacerbations and Healthcare Burden of COPD with Type 2 Inflammation: US Claims Analysis.
International journal of chronic obstructive pulmonary disease·2026